These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9050950)

  • 21. Antiestrogenic properties of raloxifene.
    Draper MW; Flowers DE; Neild JA; Huster WJ; Zerbe RL
    Pharmacology; 1995 Apr; 50(4):209-17. PubMed ID: 7792309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom).
    Verkasalo PK; Thomas HV; Appleby PN; Davey GK; Key TJ
    Cancer Causes Control; 2001 Jan; 12(1):47-59. PubMed ID: 11227925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Steroid receptor levels in human breast carcinomas in relation to serum hormone levels in postmenopausal patients (author's transl)].
    Reiner G; Bieglmayer C; Jakesz R; Kees A; Kolb R; Spona J
    Wien Klin Wochenschr; 1981 May; 93(11):339-42. PubMed ID: 6791390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients.
    Bhatavdekar JM; Patel DD; Shah NG; Giri DD; Vora HH; Karelia NH; Trivedi SN; Ghosh N; Suthar TP
    Neoplasma; 1992; 39(1):39-42. PubMed ID: 1388248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women.
    Mathur RS; Landgrebe SC; Moody LO; Semmens JP; Williamson HO
    Maturitas; 1985 Jul; 7(2):129-33. PubMed ID: 3929023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tamoxifen and partial oestrogen agonism in postmenopausal women.
    Miodrag A; Ekelund P; Burton R; Castleden CM
    Age Ageing; 1991 Jan; 20(1):52-4. PubMed ID: 1903020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid function in postmenopausal women with breast cancer on tamoxifen.
    Kostoglou-Athanassiou I; Ntalles K; Markopoulos C; Athanassiou P; Gogas J; Proukakis C
    Eur J Gynaecol Oncol; 1998; 19(2):150-4. PubMed ID: 9611055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients.
    Rose DP; Chlebowski RT; Connolly JM; Jones LA; Wynder EL
    Cancer Res; 1992 Oct; 52(19):5386-90. PubMed ID: 1394142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer.
    McFadyen IJ; Raab G; Forrest AP; Langlands AO; Stewart HJ; Roberts MM; Hamilton T; Golder MP; Groom GV; Griffiths K
    Clin Oncol; 1979 Sep; 5(3):251-6. PubMed ID: 387323
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.
    Dowsett M; Lal A; Smith IE; Jeffcoate SL
    Br J Cancer; 1987 Mar; 55(3):311-3. PubMed ID: 2952154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.
    Borkowski A; L'hermite M; Dor P; Longeval E; Rozencweig M; Muquardt C; Van Cauter E
    J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer.
    Blackburn AM; Wang DY; Bulbrook RD; Thomas BS; Kwa HG; Hoare SA; Rubens RD
    Cancer Treat Rep; 1984 Dec; 68(12):1447-53. PubMed ID: 6239689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
    De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
    Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rivizor--a new third-generation aromatase inhibitor for the treatment of advanced breast cancer after tamoxifen failure.
    Goss PE; Walde D; De Coster R; Langenaeken C; Bruynseels J
    Oncology; 1999; 56(2):114-21. PubMed ID: 9949297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden).
    Manjer J; Johansson R; Berglund G; Janzon L; Kaaks R; Agren A; Lenner P
    Cancer Causes Control; 2003 Sep; 14(7):599-607. PubMed ID: 14575357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex hormones in postmenopausal women receiving low-dose hormone therapy: the effect of BMI.
    Lambrinoudaki I; Armeni E; Rizos D; Deligeoroglou E; Kofinakos P; Kaparos G; Alexandrou A; Creatsa M; Logothetis E; Kouskouni E
    Obesity (Silver Spring); 2011 May; 19(5):988-93. PubMed ID: 20948523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
    Rannevik G; Jeppsson S; Johnell O; Bjerre B; Laurell-Borulf Y; Svanberg L
    Maturitas; 1995 Feb; 21(2):103-13. PubMed ID: 7752947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex hormones, gonadotropins and prolactin in male epileptic subjects in remission: role of the epileptic syndrome and of antiepileptic drugs.
    Murialdo G; Galimberti CA; Fonzi S; Manni R; Costelli P; Parodi C; Torre F; Solinas GP; Polleri A; Tartara A
    Neuropsychobiology; 1994; 30(1):29-36. PubMed ID: 7969856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of treatment with tamoxifen on serum levels of various steroid and protein hormones in women with breast cancer].
    Grodecka-Gazdecka S; Kociałkowski K; Chwalisz K; Baron J
    Endokrynol Pol; 1985; 36(6):341-8. PubMed ID: 3833535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.